NRX Pharmaceuticals, Inc. (NRXP) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$28.62M | -13.9% |
| 2024 | -$25.13M | +16.7% |
| 2023 | -$30.15M | +24.2% |
| 2022 | -$39.75M | +57.3% |
| 2021 | -$93.06M | -79.7% |
| 2020 | -$51.78M | -12777.2% |
| 2019 | $408.4K | +517.9% |
| 2018 | $66.1K | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$28.62M | -13.9% |
| 2024 | -$25.13M | +16.7% |
| 2023 | -$30.15M | +24.2% |
| 2022 | -$39.75M | +57.3% |
| 2021 | -$93.06M | -79.7% |
| 2020 | -$51.78M | -12777.2% |
| 2019 | $408.4K | +517.9% |
| 2018 | $66.1K | — |